Suppr超能文献

黄芩苷对呼吸系统疾病的保护作用:最新进展与未来展望

The protective effects of baicalin for respiratory diseases: an update and future perspectives.

作者信息

Song Siyu, Ding Lu, Liu Guangwen, Chen Tian, Zhao Meiru, Li Xueyan, Li Min, Qi Hongyu, Chen Jinjin, Wang Ziyuan, Wang Ying, Ma Jing, Wang Qi, Li Xiangyan, Wang Zeyu

机构信息

Key Laboratory of Active Substances and Biological Mechanisms of Ginseng Efficacy, Jilin Provincial Key Laboratory of Bio-Macromolecules of Chinese Medicine, Ministry of Education, Northeast Asia Research Institute of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China.

GCP Department, Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China.

出版信息

Front Pharmacol. 2023 Mar 16;14:1129817. doi: 10.3389/fphar.2023.1129817. eCollection 2023.

Abstract

Respiratory diseases are common and frequent diseases. Due to the high pathogenicity and side effects of respiratory diseases, the discovery of new strategies for drug treatment is a hot area of research. Georgi (SBG) has been used as a medicinal herb in China for over 2000 years. Baicalin (BA) is a flavonoid active ingredient extracted from SBG that BA has been found to exert various pharmacological effects against respiratory diseases. However, there is no comprehensive review of the mechanism of the effects of BA in treating respiratory diseases. This review aims to summarize the current pharmacokinetics of BA, baicalin-loaded nano-delivery system, and its molecular mechanisms and therapeutical effects for treating respiratory diseases. This review reviewed databases such as PubMed, NCBI, and Web of Science from their inception to 13 December 2022, in which literature was related to "baicalin", " Georgi", "COVID-19", "acute lung injury", "pulmonary arterial hypertension", "asthma", "chronic obstructive pulmonary disease", "pulmonary fibrosis", "lung cancer", "pharmacokinetics", "liposomes", "nano-emulsions", "micelles", "phospholipid complexes", "solid dispersions", "inclusion complexes", and other terms. The pharmacokinetics of BA involves mainly gastrointestinal hydrolysis, the enteroglycoside cycle, multiple metabolic pathways, and excretion in bile and urine. Due to the poor bioavailability and solubility of BA, liposomes, nano-emulsions, micelles, phospholipid complexes, solid dispersions, and inclusion complexes of BA have been developed to improve its bioavailability, lung targeting, and solubility. BA exerts potent effects mainly by mediating upstream oxidative stress, inflammation, apoptosis, and immune response pathways. It regulates are the NF-κB, PI3K/AKT, TGF-β/Smad, Nrf2/HO-1, and ERK/GSK3β pathways. This review presents comprehensive information on BA about pharmacokinetics, baicalin-loaded nano-delivery system, and its therapeutic effects and potential pharmacological mechanisms in respiratory diseases. The available studies suggest that BA has excellent possible treatment of respiratory diseases and is worthy of further investigation and development.

摘要

呼吸系统疾病是常见且多发的疾病。由于呼吸系统疾病的高致病性和副作用,探索新的药物治疗策略是一个热门研究领域。黄芩在中国作为草药使用已有2000多年历史。黄芩苷是从黄芩中提取的一种黄酮类活性成分,已发现其对呼吸系统疾病具有多种药理作用。然而,目前尚无关于黄芩苷治疗呼吸系统疾病作用机制的全面综述。本综述旨在总结黄芩苷目前的药代动力学、载黄芩苷纳米给药系统及其治疗呼吸系统疾病的分子机制和治疗效果。本综述检索了PubMed、NCBI和Web of Science等数据库,检索时间从建库至2022年12月13日,检索文献涉及“黄芩苷”“黄芩”“新型冠状病毒肺炎”“急性肺损伤”“肺动脉高压”“哮喘”“慢性阻塞性肺疾病”“肺纤维化”“肺癌”“药代动力学”“脂质体”“纳米乳剂”“胶束”“磷脂复合物”“固体分散体”“包合物”等关键词。黄芩苷的药代动力学主要涉及胃肠道水解、肠苷循环、多种代谢途径以及胆汁和尿液排泄。由于黄芩苷的生物利用度和溶解度较差,已开发出其脂质体、纳米乳剂、胶束、磷脂复合物、固体分散体和包合物,以提高其生物利用度、肺靶向性和溶解度。黄芩苷主要通过介导上游氧化应激、炎症、细胞凋亡和免疫反应途径发挥强大作用。它调节的是核因子-κB、磷脂酰肌醇-3激酶/蛋白激酶B、转化生长因子-β/信号转导和转录激活因子、核因子E2相关因子2/血红素加氧酶-1以及细胞外信号调节激酶/糖原合成酶激酶-3β信号通路。本综述提供了关于黄芩苷药代动力学、载黄芩苷纳米给药系统及其在呼吸系统疾病中的治疗效果和潜在药理机制的全面信息。现有研究表明,黄芩苷在治疗呼吸系统疾病方面具有良好的潜力,值得进一步研究和开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f3a/10060540/1f495c4dc63e/fphar-14-1129817-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验